APPLICATION
ANDA203190
TYPE
ANDA
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION
MARKETING STATUS
None (Tentative Approval)
Products
GATIFLOXACINNone (Tentative Approval)
GATIFLOXACIN 0.3% · SOLUTION · OPHTHALMIC
Approval history
2014-04-09UNKNOWN · OriginalTA
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.